Nuzenio

Ionis Pharmaceuticals

Ionis Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 21 latest news signals 14 publisher sources 100/100 entity strength

Latest news

IONS Investors Have Opportunity to Join Ionis Pharmaceuticals, Inc. Fraud Investigation with SBS Law - Business WireBusiness Wire · Sat, 08 Aug 2026 20:07:00 GMTIs Ionis Pharmaceuticals (IONS) Cheap On Its Earnings Miss And CSO Retirement? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 10:53:06 GMTIonis Pharmaceuticals Inc. R (ISI.DU) Q1 FY2026 earnings call transcript - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 10:52:30 GMTINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS - PR NewswirePR Newswire · Fri, 07 Aug 2026 03:02:00 GMTArrowhead buys PRV for $215M; Twist hopes to raise $300M in public offering - Endpoints NewsEndpoints News · Wed, 05 Aug 2026 14:28:00 GMTH.C. Wainwright Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $115 - MoomooMoomoo · Wed, 05 Aug 2026 10:35:01 GMTIonis Pharmaceuticals, Inc. (IONS) Stock forecasts - Yahoo Finance UKYahoo Finance UK · Wed, 05 Aug 2026 07:31:49 GMTMichael Hayden Bought 34% More Shares In Ionis Pharmaceuticals - SahmSahm · Tue, 04 Aug 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 20:07:00 GMTIONS Investors Have Opportunity to Join Ionis Pharmaceuticals, Inc. Fraud Investigation with SBS Law - Business Wire
Fri, 07 Aug 2026 10:53:06 GMTIs Ionis Pharmaceuticals (IONS) Cheap On Its Earnings Miss And CSO Retirement? - simplywall.st
Fri, 07 Aug 2026 10:52:30 GMTIonis Pharmaceuticals Inc. R (ISI.DU) Q1 FY2026 earnings call transcript - Yahoo Finance
Fri, 07 Aug 2026 03:02:00 GMTINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS - PR Newswire
Wed, 05 Aug 2026 14:28:00 GMTArrowhead buys PRV for $215M; Twist hopes to raise $300M in public offering - Endpoints News
Wed, 05 Aug 2026 10:35:01 GMTH.C. Wainwright Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $115 - Moomoo

Related explainers

PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ionis Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.